ONTRUZANT is Samsung Bioepis’ first oncology biosimilar available in the United States ... Apr 16
Samsung Bioepis’ BRENZYS™ (etanercept) becomes available in Brazil through Brazil’s public health system, Sistema Único de Saúde (SUS) Established seven years ago, Samsung ... Sep 11
-Advertisements-